Community pharmacies play a pivotal role in outpatient antibiotic use; however, antimicrobial stewardship (AMS) in this setting remains fragmented and less developed than in hospital environments. Data-driven approaches are increasingly emerging as a means to strengthen AMS in community pharmacies. The growing use of dispensing data, prescribing records, point-of-care testing results, and patient-level information is beginning to inform how pharmacists triage patients, audit antimicrobial use, and optimise therapy.

Chair:

- Luna ElBizri, Founder and manager of Lunapharm Pharmacy, Lebanon

Panellists:

- Federico Zerbinato, Pharmacist, Robert Gordon University, UK

- Usman Abubakar, Assistant Professor, College of Pharmacy, Qatar University, Qatar

- Abdullah Al Masud, Post Doctoral Research Associate, University of New South Wales, Australia

This webinar will provide a structured and practical overview of Bioclassification System (BCS)-based biowaivers under ICH M9. BCS-based biowaivers are an important scientific approach to avoid unnecessary in vivo bioequivalence studies, while maintaining confidence in product performance. However, their application requires a clear understanding of solubility, permeability, formulation prerequisites, and dissolution behavior. The event will explain the underlying scientific concepts, decision logic, and common pitfalls using practical examples. Special emphasis will be placed on dissolution as a key link between the drug substance, the formulation, and in vivo performance.

Moderator:

- Horst-Dieter Friedel, Former Director - retired, Worked for Bayer AG, Chair of FIP SIG Regulatory Sciences and Quality, Germany

Panellist:

- Hiroyuki Yoshida, Chief of the First Section, National Institute of Health Sciences, Member of FIP Focus Group Dissolution/Drug Release, Japan

The FIPWiSE Global Online Summit 2026 will take place on 11 February to mark the UN International Day of Women and Girls in Science and celebrate six years of FIPWiSE. This interactive three-hour virtual event will spotlight women’s leadership, resilience, and innovation across pharmacy and pharmaceutical sciences, aligning with global imperatives for equity and inclusive health systems. Bringing together partners such as WHO, UNESCO and UN Women, the summit will feature global dialogue, stories of resilience, and future-focused discussions, culminating in a collective FIP Pledge for Women in Pharmacy and Society to advance gender equity and inclusive leadership worldwide.

ISOPP International Symposium 2026

Format: 24-Hour Virtual Symposium (“Around the World”)

Purpose & Features:

• To bring together oncology pharmacy professionals globally for sharing research, innovation, best practices.
• 30 sessions, each 30 minutes, in celebration of ISOPP’s 30th anniversary.
• Keynote & panel sessions, interactive workshops / live discussions, networking, on-demand access for those who can’t attend all live sessions.

 International Society of Oncology Pharmacy Practitioners (ISOPP) invites submissions of abstracts for its 2026 symposium. This event welcomes oncology pharmacy practitioners, researchers, and those involved in service evaluation or clinical audit. Key deadlines: abstracts due 31 October 2025. Accepted abstracts will be published in the Journal of Oncology Pharmacy Practice.